{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:33:45Z","timestamp":1793968425053,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangxi Provincial Health Technology Project","award":["Grant No. 202510154"],"award-info":[{"award-number":["Grant No. 202510154"]}]},{"name":"Jiangxi Provincial Health Technology Project","award":["Grant No. 202510154"],"award-info":[{"award-number":["Grant No. 202510154"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Systemic lupus erythematosus (SLE) is an incurable autoimmune disease that affects body tissues, but it can be managed with medication. Although therapeutic strategies for SLE have advanced, the underlying molecular mechanisms driving disease pathogenesis remain incompletely understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study analyzed gene expression data from three GEO microarray datasets to explore immunity-related differentially expressed genes (DEGs) in SLE. Using WGCNA, we identified gene modules and integrated them with immune-related DEGs to find candidate hub genes, which were validated using RT-qPCR. We constructed a PPI network and performed gene enrichment analysis to identify nine hub genes through ROC curve analysis. We confirmed the link between these hub genes and immune cells, conducted GSEA, and predicted drugs, miRNAs, and transcription factors (TFs) targeting these genes. LASSO and ROC analyses validated a model using immunity-related DEGs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The forty immune-related DEGs were identified from a total of 1590 DEGs, 452 WGCN module genes, and 1791 immune genes. Nine hub genes (<jats:italic>MX1<\/jats:italic>, <jats:italic>OAS1<\/jats:italic>, <jats:italic>OASL<\/jats:italic>, <jats:italic>IRF7<\/jats:italic>, <jats:italic>RSAD2<\/jats:italic>, <jats:italic>EIF2AK2<\/jats:italic>, <jats:italic>ISG15<\/jats:italic>, <jats:italic>IFIH1<\/jats:italic>, and <jats:italic>STAT1<\/jats:italic>) were highlighted using Cytoscape and ROC analysis, with an AUC greater than 0.7. RT-qPCR confirmed significant overexpression of all hub genes except <jats:italic>STAT1<\/jats:italic> in SLE. ssGSEA and GSEA linked these genes to immune cell infiltration and pathways, including \"cell cycle\" and \"RIG-I-like receptor signaling.\" A diagnostic model with three immune-related hub genes (<jats:italic>MX1<\/jats:italic>, <jats:italic>IRF7<\/jats:italic>, and <jats:italic>EIF2AK2<\/jats:italic>) demonstrated high accuracy (AUC &gt; 0.8) in distinguishing SLE from healthy controls. Additionally, 9 target drugs, 14 target miRNAs, and 23 TFs were identified for these hub genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>MX1, IRF7, and EIF2AK2 may serve as candidate biomarkers for SLE and warrant further investigation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02953-1","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:46:36Z","timestamp":1753854396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of differentially expressed immune-related genes in patients with systemic lupus erythematosus and the development of a hub gene-based diagnostic model"],"prefix":"10.1186","volume":"30","author":[{"given":"Quangang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"17","key":"2953_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: A review. JAMA. 2024;331(17):1480\u201391.","journal-title":"JAMA"},{"issue":"10441","key":"2953_CR2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet (London, England). 2024;403(10441):2326\u201338.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"2953_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.bor.0000172799.03379.86","volume":"17","author":"DR Karp","year":"2005","unstructured":"Karp DR. Complement and systemic lupus erythematosus. Curr Opin Rheumatol. 2005;17(5):538\u201342.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2953_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/1516-3180.2018.0258060219","volume":"137","author":"V \u017divkovi\u0107","year":"2019","unstructured":"\u017divkovi\u0107 V, Miti\u0107 B, Stamenkovi\u0107 B, Stojanovi\u0107 S, Dini\u0107 BR, Stojanovi\u0107 M, et al. Analysis on the risk factors for organ damage in patients with systemic lupus erythematosus: a cross-sectional single-center experience. Sao Paulo Med J. 2019;137(2):155\u201361.","journal-title":"Sao Paulo Med J"},{"key":"2953_CR5","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2953_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","volume":"23","author":"L Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: An update. Autoimmunity Rev. 2024;23(10): 103648.","journal-title":"Autoimmunity Rev"},{"issue":"7","key":"2953_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/biom11070928","volume":"11","author":"H Yu","year":"2021","unstructured":"Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11(7):928.","journal-title":"Biomolecules"},{"issue":"6","key":"2953_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00296-017-3888-x","volume":"38","author":"V \u017divkovi\u0107","year":"2018","unstructured":"\u017divkovi\u0107 V, Cvetkovi\u0107 T, Miti\u0107 B, Stamenkovi\u0107 B, Stojanovi\u0107 S, Radovanovi\u0107-Dini\u0107 B, et al. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study. Rheumatol Int. 2018;38(6):1003\u20138.","journal-title":"Rheumatol Int"},{"issue":"8","key":"2953_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82(8):999\u20131014.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2953_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.imbio.2011.07.026","volume":"217","author":"T Srdic-Rajic","year":"2012","unstructured":"Srdic-Rajic T, Jurisic V, Andrejevic S, Bonaci-Nikolic B, Bowker T, Concas D, et al. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA. Immunobiology. 2012;217(1):111\u20137.","journal-title":"Immunobiology"},{"key":"2953_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668007","volume":"12","author":"Q Fang","year":"2021","unstructured":"Fang Q, Li T, Chen P, Wu Y, Wang T, Mo L, et al. Comparative analysis on abnormal methylome of differentially expressed genes and disease pathways in the immune cells of RA and SLE. Front Immunol. 2021;12: 668007.","journal-title":"Front Immunol"},{"issue":"5","key":"2953_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S","volume":"41","author":"DA Horwitz","year":"1998","unstructured":"Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 1998;41(5):838\u201344.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2953_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916934.2015.1037441","volume":"48","author":"D Li","year":"2015","unstructured":"Li D, Guo B, Wu H, Tan L, Chang C, Lu Q. Interleukin-17 in systemic lupus erythematosus: A comprehensive review. Autoimmunity. 2015;48(6):353\u201361.","journal-title":"Autoimmunity"},{"issue":"8","key":"2953_CR14","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.39665","volume":"68","author":"T Koga","year":"2016","unstructured":"Koga T, Otomo K, Mizui M, Yoshida N, Umeda M, Ichinose K, et al. Calcium\/calmodulin-dependent kinase IV facilitates the recruitment of interleukin-17-producing cells to target organs through the CCR6\/CCL20 axis in Th17 cell-driven inflammatory diseases. Arthritis Rheumatol (Hoboken, NJ). 2016;68(8):1981\u20138.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"19","key":"2953_CR15","doi-asserted-by":"publisher","first-page":"14413","DOI":"10.3390\/ijms241914413","volume":"24","author":"P Richter","year":"2023","unstructured":"Richter P, Macovei LA, Mihai IR, Cardoneanu A, Burlui MA, Rezus E. Cytokines in systemic lupus erythematosus-focus on TNF-\u03b1 and IL-17. Int J Mol Sci. 2023;24(19):14413.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2953_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatrics WJP. 2020;16(1):19\u201330.","journal-title":"World J Pediatrics WJP"},{"issue":"4\u20135","key":"2953_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0961203314556139","volume":"24","author":"D Comte","year":"2015","unstructured":"Comte D, Karampetsou MP, Tsokos GC. T cells as a therapeutic target in SLE. Lupus. 2015;24(4\u20135):351\u201363.","journal-title":"Lupus."},{"issue":"6","key":"2953_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1515\/mr-2023-0032","volume":"3","author":"H Huang","year":"2023","unstructured":"Huang H. Immunotherapeutic approaches for systemic lupus erythematosus: early overview and future potential. Med Rev (2021). 2023;3(6):452\u201364.","journal-title":"Med Rev (2021)"},{"issue":"Suppl 1","key":"2953_CR19","doi-asserted-by":"publisher","first-page":"i22","DOI":"10.1093\/rheumatology\/keac678","volume":"62","author":"J He","year":"2023","unstructured":"He J, Li Z. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus. Rheumatology (Oxford, England). 2023;62(Suppl 1):i22\u20139.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"2953_CR20","first-page":"882","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford, England). 2012;28(6):882\u20133.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"2953_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"2953_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"W1","key":"2953_CR23","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2953_CR24","doi-asserted-by":"publisher","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","volume":"46","author":"KC Cotto","year":"2018","unstructured":"Cotto KC, Wagner AH, Feng YY, Kiwala S, Coffman AC, Spies G, et al. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 2018;46(D1):D1068\u201373.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2953_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1358\/dot.2022.58.1.3352743","volume":"58","author":"Y Fan","year":"2022","unstructured":"Fan Y, Gao D, Zhang Z. Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus. Drugs Today. 2022;58(1):23\u201332.","journal-title":"Drugs Today"},{"issue":"11","key":"2953_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Internal Med. 2020;172(11):81\u201396.","journal-title":"Ann Internal Med"},{"key":"2953_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-15-4494-1_1","volume":"1255","author":"B Yu","year":"2020","unstructured":"Yu B, Li L, Zhang J, Wang X, Zeng Y. Understanding diseases from single-cell sequencing and methylation. Adv Exp Med Biol. 2020;1255:1\u20136.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2953_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1182\/blood.2022016954","volume":"141","author":"I Iacobucci","year":"2023","unstructured":"Iacobucci I, Witkowski MT, Mullighan CG. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood. 2023;141(4):356\u201368.","journal-title":"Blood"},{"key":"2953_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12935-019-0858-2","volume":"19","author":"GM Liu","year":"2019","unstructured":"Liu GM, Zeng HD, Zhang CY, Xu JW. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2953_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","volume":"19","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhang L, Wang J, Zhang M, Song Z, Ni B, et al. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35.","journal-title":"J Transl Med"},{"issue":"23","key":"2953_CR31","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.21037\/atm-20-7507","volume":"8","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang M, Chen X, He Y, Chen R, Zhang J, et al. Identification of the tubulointerstitial infiltrating immune cell landscape and immune marker related molecular patterns in lupus nephritis using bioinformatics analysis. Ann Transl Med. 2020;8(23):1596.","journal-title":"Ann Transl Med"},{"issue":"Pt B","key":"2953_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110968","volume":"124","author":"S Song","year":"2023","unstructured":"Song S, Zhang JY, Liu FY, Zhang HY, Li XF, Zhang SX. B cell subsets-related biomarkers and molecular pathways for systemic lupus erythematosus by transcriptomics analyses. Int Immunopharmacol. 2023;124(Pt B): 110968.","journal-title":"Int Immunopharmacol"},{"key":"2953_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969509","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Ma C, Liao S, Qi S, Meng S, Cai W, et al. Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus. Front Immunol. 2022;13: 969509.","journal-title":"Front Immunol"},{"key":"2953_CR34","doi-asserted-by":"publisher","first-page":"1476575","DOI":"10.3389\/fimmu.2025.1476575","volume":"16","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Li H, Wang Y, Huang L, Chen L, Lin S, et al. Identification and immunoassay of biomarkers associated with T cell exhaustion in systemic lupus erythematosus. Front Immunol. 2025;16:1476575.","journal-title":"Front Immunol"},{"issue":"1","key":"2953_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nsmb.1529","volume":"16","author":"S Rothenburg","year":"2009","unstructured":"Rothenburg S, Seo EJ, Gibbs JS, Dever TE, Dittmar K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat Struct Mol Biol. 2009;16(1):63\u201370.","journal-title":"Nat Struct Mol Biol"},{"issue":"7413","key":"2953_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature11290","volume":"488","author":"B Lu","year":"2012","unstructured":"Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundb\u00e4ck P, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488(7413):670\u20134.","journal-title":"Nature"},{"issue":"5","key":"2953_CR37","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","volume":"13","author":"W Wei","year":"2023","unstructured":"Wei W, Zeng Q, Wang Y, Guo X, Fan T, Li Y, et al. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharma Sin B. 2023;13(5):2138\u201351.","journal-title":"Acta Pharma Sin B"},{"issue":"45","key":"2953_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031522","volume":"101","author":"E Suzuki","year":"2022","unstructured":"Suzuki E, Zhang XK, Yashiro-Furuya M, Asano T, Kanno T, Kobayashi H, et al. The expression of Ets-1 and Fli-1 is associated with interferon-inducible genes in peripheral blood mononuclear cells from Japanese patients with systemic lupus erythematosus. Medicine. 2022;101(45): e31522.","journal-title":"Medicine"},{"key":"2953_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.molimm.2021.01.030","volume":"132","author":"L Ge","year":"2021","unstructured":"Ge L, Zhang Y, Zhao X, Wang J, Zhang Y, Wang Q, et al. EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus. Mol Immunol. 2021;132:132\u201341.","journal-title":"Mol Immunol"},{"issue":"4","key":"2953_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"CX Liu","year":"2019","unstructured":"Liu CX, Li X, Nan F, Jiang S, Gao X, Guo SK, et al. Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell. 2019;177(4):865-80.e21.","journal-title":"Cell"},{"issue":"3","key":"2953_CR41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2017.03.101","volume":"486","author":"SW Hwang","year":"2017","unstructured":"Hwang SW, Kim D, Jung JU, Lee HR. KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production. Biochem Biophys Res Commun. 2017;486(3):700\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"2953_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00579-17","volume":"91","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa Y, Sakai M, Funayama M, Itoh M, Gotoh B. Human metapneumovirus M2\u20132 protein acts as a negative regulator of alpha interferon production by plasmacytoid dendritic cells. J Virol. 2017;91(20): e00579-17.","journal-title":"J Virol"},{"issue":"6","key":"2953_CR43","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2007.05.019","volume":"129","author":"D Panne","year":"2007","unstructured":"Panne D, Maniatis T, Harrison SC. An atomic model of the interferon-beta enhanceosome. Cell. 2007;129(6):1111\u201323.","journal-title":"Cell"},{"issue":"6515","key":"2953_CR44","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (New York, NY). 2020;370(6515):eabd4570.","journal-title":"Science (New York, NY)"},{"issue":"6","key":"2953_CR45","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1084\/jem.20042372","volume":"201","author":"S Uematsu","year":"2005","unstructured":"Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med. 2005;201(6):915\u201323.","journal-title":"J Exp Med"},{"issue":"5","key":"2953_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637\u201350.","journal-title":"Immunity"},{"key":"2953_CR47","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.2147\/IJGM.S416493","volume":"16","author":"Z Pan","year":"2023","unstructured":"Pan Z, Yang Q, Zhang X, Xu X, Sun Y, Zhou F, et al. TRIM5 promotes systemic lupus erythematosus through CD4(+) T cells and macrophage. Int J Gen Med. 2023;16:3567\u201380.","journal-title":"Int J Gen Med"},{"issue":"10","key":"2953_CR48","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s10067-023-06597-6","volume":"42","author":"A Kim","year":"2023","unstructured":"Kim A, Choi SJ, Song GG, Kim JH, Jung JH. Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus. Clin Rheumatol. 2023;42(10):2799\u2013809.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2953_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26022","volume":"10","author":"M Wang","year":"2024","unstructured":"Wang M, Zhang Y, Zhai Y, Li H, Xie Z, Wen C. The mechanism of Langchuangding in treatment of systemic lupus erythematosus via modulating TLR7-IRF7-IFN\u03b1 pathway. Heliyon. 2024;10(5): e26022.","journal-title":"Heliyon"},{"issue":"1\u20134","key":"2953_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000103200","volume":"117","author":"T Watanabe","year":"2007","unstructured":"Watanabe T. Polymorphisms of the chicken antiviral MX gene. Cytogenetic Genome Res. 2007;117(1\u20134):370\u20135.","journal-title":"Cytogenetic Genome Res"},{"issue":"3","key":"2953_CR51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1128\/jvi.64.3.1171-1181.1990","volume":"64","author":"MA Horisberger","year":"1990","unstructured":"Horisberger MA, McMaster GK, Zeller H, Wathelet MG, Dellis J, Content J. Cloning and sequence analyses of cDNAs for interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: functional study of the corresponding gene promoter. J Virol. 1990;64(3):1171\u201381.","journal-title":"J Virol"},{"issue":"4 Pt 2","key":"2953_CR52","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S67","volume":"152","author":"MA Horisberger","year":"1995","unstructured":"Horisberger MA. Interferons, Mx genes, and resistance to influenza virus. Am J Respir Crit Care Med. 1995;152(4 Pt 2):S67-71.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2953_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0092-8674(86)90493-9","volume":"44","author":"P Staeheli","year":"1986","unstructured":"Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell. 1986;44(1):147\u201358.","journal-title":"Cell"},{"issue":"4","key":"2953_CR54","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14(4):778\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"2953_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1593\/neo.91110","volume":"11","author":"MF Calmon","year":"2009","unstructured":"Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD, et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia (New York, NY). 2009;11(12):1329\u201339.","journal-title":"Neoplasia (New York, NY)"},{"issue":"4","key":"2953_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/14397595.2017.1404711","volume":"28","author":"Y Shimizu","year":"2018","unstructured":"Shimizu Y, Yasuda S, Kimura T, Nishio S, Kono M, Ohmura K, et al. Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-na\u00efve lupus nephritis, but not in those under immunosuppressive treatment. Mod Rheumatol. 2018;28(4):661\u20139.","journal-title":"Mod Rheumatol"},{"key":"2953_CR57","doi-asserted-by":"publisher","first-page":"1351446","DOI":"10.3389\/fimmu.2024.1351446","volume":"15","author":"I Cecchi","year":"2024","unstructured":"Cecchi I, Radin M, Barinotti A, Foddai SG, Menegatti E, Roccatello D, et al. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation. Front Immunol. 2024;15:1351446.","journal-title":"Front Immunol"},{"issue":"1","key":"2953_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10067-014-2799-4","volume":"34","author":"X Feng","year":"2015","unstructured":"Feng X, Huang J, Liu Y, Xiao L, Wang D, Hua B, et al. Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus. Clin Rheumatol. 2015;34(1):71\u20139.","journal-title":"Clin Rheumatol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02953-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:08:47Z","timestamp":1757322527000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02953-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02953-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GEO is a public database containing ethically approved patient data. Users can freely download this data for research and publication purposes. This study, which utilizes open-source data from GEO, has no ethical concerns or conflicts of interest. Human protocols adhered to the Ethical Guidelines of the Declaration of Helsinki. The Jiangxi Provincial People's Hospital Ethics Committee (JXPPH-202310017) approved this study. All participants provided written informed consent, and all procedures followed relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors know and approve the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"689"}}